Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer
1993 ◽
Vol 4
(5)
◽
pp. 423-425
◽
Richard S. Finn
◽
John P. Crown
◽
Istvan Lang
◽
Katalin Boer
◽
Igor M. Bondarenko
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 728-728
◽
A. Polyzos
◽
D. Mavroudis
◽
J. Boukovinas
◽
E. Tsiakopoulos
◽
N. Malamos
◽
...
2004 ◽
Vol 2
(3)
◽
pp. 129
S Barni
◽
P Colina
◽
S Leo
◽
P Sandri
◽
A Savarino
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 728-728
◽
A. Polyzos
◽
D. Mavroudis
◽
J. Boukovinas
◽
E. Tsiakopoulos
◽
N. Malamos
◽
...
2005 ◽
Vol 92
(6)
◽
pp. 1013-1018
◽
K H Yeh
◽
Y S Lu
◽
C H Hsu
◽
J F Lin
◽
H J Chao
◽
...
2018 ◽
Vol 109
(3)
◽
pp. 803-813
◽
Norikazu Masuda
◽
Reiki Nishimura
◽
Masato Takahashi
◽
Kenichi Inoue
◽
Shinji Ohno
◽
...
F. Giotta
◽
L. Manzione
◽
V. Gebbia
◽
D. Bilancia
◽
N. Gebbia
◽
...
Laura Biganzoli
◽
Saverio Cinieri
◽
Rossana Berardi
◽
Rebecca Pedersini
◽
Amelia McCartney
◽
...
1996 ◽
Vol 7
(2)
◽
pp. 165-171
◽
P. Fumoleau
◽
B. Chevallier
◽
P. Kerbrat
◽
Y. Krakowski
◽
J.-L. Misset
◽
...
S. Hurvitz
◽
M. Pegram
◽
L. Lin
◽
D. Chan
◽
H. Allen
◽
...